Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To this point, they have been their own—and our—worst enemy.
I suppose my question in (3) is: how can CELZ be lucrative and valuable on the one hand, but have a PPS that is in the thousandths in comparison to a large number of other stem cell players?
Fair points in theory. Are you also willing to consider that (and I’m eager to read your thoughts):
1. In addition to awaiting results, docs may also be reluctant because they think they can inject the stem cells on their own, using some means other than CELZ’ kit?
2. In this event, the already cash-strapped company would need to pay to pursue patent enforcement?
3. Several other companies with MUCH higher PPS are legitimately valued, as are we (I don’t tend to believe this, but at some point one has to wonder)
Answers to these and other questions are HORRIBLY overdue—and in the absence of them, we are holding a fairly worthless bag.
Why is Dr. Ichim’s other company popping, while this is flopping? Why haven’t we gotten a shareholder update in going on two months? Why does it seem like doctors are reluctant to sign up? Will we see the same problem with the other product lines? How do they plan to protect their patents when all they seem so sell is a kit that they get from a third party vendor?
There are some posters here who are invested and have been for going on two years—who would nonetheless like to know too. What is the basis for optimism? Weren’t we told in Sept 2018 that existing debt was restructured more favorably and that money going forward was then available for commercializing the ENTIRE SUITE of items in their portfolio? So why all the additional notes (and shares to go with them)?
They only give out that kind of information to folks who are authorized to receive it: you know that and I know that. Normal folks can either (1) wait for official company PRs and/or (2) use knowledge of procedural regulations and critical thinking to infer what will happen.
Same here.
What are the notification requirements regarding the proposed R/S. According to the filings, if effected as proposed, it must occur by 12/30/19. Can anyone provide information (with source) showing how much before that they must notify shareholders? I have to think we’re close to that time (if not already past it)...
Someone trades 100 shares at the open—and the PPS drops one tick (33%): how does THAT happen?
Their MO from the past was reverse merger—and Tim subtly dropped that phrase in his October podcast
A part of me has wondered for some time whether Tim might be using the capital proceeds from recent notes to buy big volumes of shares: for me, the related and REALLY important question is “what is the SOURCE of all these shares?”
After seeing the bid volume much higher than the ask volume for the better part of the last few weeks, now the ask is stacked.
I’m just capturing the essence of what they have said formally in writing—not making too many qualitative judgments beyond that.
So clearly the 1:50 R/S isn’t likely to occur at these price levels—given that, at .0002, the PPS would rise only to .01 (which kinda defeats the logic of doing the R/S for OTCQB status.
I didn’t have any luck finding anything here:
https://otce.finra.org/otce/home
And according to this site, FINRA doesn’t “approve” reverse splits:
https://www.finra.org/investors/insights/you-asked-we-answered-what-is-reverse-stock-split
I agree absolutely. WHO?
Keep in mind that the 100M+ shares was just yesterday’s volume: since the R/S was first mentioned in mid-October we’re probably talking about accumulation of somewhere around half a billion shares or more...
.....aaaaaand then they dumped the ever-loving F outta some shares.
At this point I’m wondering whether a hostile takeover (not likely) would actually BENEFIT the shareholders!
Severe losses would be sustained. Losses may never be recovered EVER, but would certainly not be by selling at these levels. More “gratitude” for us true longs, who continue to suffer with no end in sight—despite evidently hollow promises to “be rewarded soon”...
Yes, we’ve seen mention of CaverStem in a few places like that—but absolutely ZERO traction with the PPS (in fact, grotesque and longstanding retracement all the way to the bottom of the basement).
More generally, when you search for the most prominent stem cell companies (the ones with significant market caps backed by real money), CELZ doesn’t even make “footnote” status among the honorable mentions.
Funny thing—so many companies mentioned as being at the forefront of stem cell medicine, and they have stock prices that corroborate that interest (huge, multi-dollar prices in fact): CELZ is never mentioned in this company. Sorry to point out the gorilla in the room: this is a business, they are in charge, results matter. No more blind hope and obsequious following...
1.5 years old
Worth the read--especially the "revisiting the fundamentals" section and what follows it:
https://emerginggrowth.com/creative-medical-technology-holdings-otcqb-celz-do-not-bet-on-this-biotechs-erectile-dysfunction-treatment-procedure/
If they conduct the R/S, they can kiss this company—and the reputations of all associated with it—goodbye. Pretty straightforward at this point...
So why, after roughly two years of underwhelming underperformance—directly derived from an inability to communicate any clear and compelling sense of business costs, profit projections, revenue streams, and training timelines—should we NOW expect something so radically different within 3 weeks (all that’s left until they are required to effect the R/S)? Oh BTW: there’s no 10-Q due until Feb, so where’s the catalyst? And if it DOES exist, why has it been withheld while our shareholder value (PPS) has been driven into the dust?
So far no email in my TDA inbox. Anyone else? Other brokers?
Postmarked? Received? Where does it stipulate that?
According to filings, agreement with lenders requires that R/S be effected prior to 12/30/19, and filings do not mention provisions for this requirement to be lifted...
Sadly, the FACTS are on your side. They have done almost NOTHING to stabilize the PPS—which is the only object measure of shareholder value, though it is a derivative of other “value drivers” that ARE more immediately within their control. What in the name of all that is holy are they waiting for? Why allow the absolute decimation of the very shareholders you claim to value? If what they claim about IP is true, this should be making strong and steady progress toward dollars NOW. It isn’t...
What—at .01 AFTER the 1:50 R/S? Why is my blood boiling AGAIN?!
And it doesn’t look like the clouds will be parting anytime soon: beyond the convertible notes and related dilution we’ve been dealing with over the last year, there are other notes that stretch well into mid-late 2020. Add this to the imminent R/S: more “shareholder value”!
What idea? They’ve been so quiet for so long I’ve lost track of our cognitive baseline (as if they ever really established it clearly and explicitly to begin with).
If I believed for ONE SECOND that they were truly eager to make us all wealthy (as opposed to dividing our share counts by a 1:50 factor), I’d buy another 25-50 MILLION shares without blinking an eye. However, at some point RESULTS MATTER—and right now the results (as measured by PPS action) have been catastrophically bad (.07 to .0002).
I work all hours of the day and night—multiple jobs, my man. Investing in CELZ cost me dearly, but I’m willing to ride this out with the expectation that they will do what’s right and prove themselves to be worthy of our trust and support. So far they have DESTROYED them—and time is running out...
+1
All trust—no verify...